An approach to gut microbiota profile in children with autism spectrum disorder.
Pedro Andreo-MartínezNuria García-MartínezElvira Pilar Sánchez-SamperAgustin Ernesto Martínez-GonzálezPublished in: Environmental microbiology reports (2019)
In recent years, there has been an increase in studies on the implications of gut microbiota (GM) on the behaviour of children with autism spectrum disorders (ASD) due to a dysbiosis in GM that can trigger onset, development or progression of ASD through the microbiota-gut-brain axis. The aim of this study is to carry out a systematic review of articles from the last 6 years that analyse GM in children with ASD compared to GM in control groups. Children with ASD showed a higher abundance of Roseburia and Candida genera, and lower abundance of Dialister, Bilophila, Veillonella, Streptococcus, Coprococcus and Prevotella genera. Those differences can be attributed to factors such as different nationalities, nature of control groups, place where the sample was taken, gastrointestinal (GI) problems or bacterial detection methods. It is still too early to define a specific GM profile of children with ASD, and future studies should focus on homogenizing the characteristics of samples and control groups. Furthermore, new multicentre studies should also focus on the impact of GM on GI physiology, neurophysiology and behaviour of children with ASD, and on performing psychometric analyses of the correlation between the severity of ASD behavioural symptoms and GM profiles.
Keyphrases
- autism spectrum disorder
- attention deficit hyperactivity disorder
- young adults
- intellectual disability
- mental health
- clinical trial
- randomized controlled trial
- physical activity
- case control
- brain injury
- depressive symptoms
- study protocol
- blood brain barrier
- working memory
- pseudomonas aeruginosa
- sleep quality
- quantum dots
- label free